SOFINNOVA PARTNERS SASLuck factor —Luck data is unavailable for this scope.

Follow this organization across linked issuers and source filings.

OrganizationFRFrance public disclosures

Companies in disclosed relationships

Public filings

Net disclosed balance

€9,977,500.00

Latest filing

6 Mar 2023

How figures are calculated and what is excluded

Signals Pro

Average share-price change 3, 6 and 12 months after each buy

Insider	3 months	6 months	12 months
Insider A	+4.2%	+8.5%	+15.8%
Insider B	+2.6%	+6.1%	+11.4%
Insider C	-1.2%	+3.4%	+7.2%

What happened after each trade?

Go from a single score to the subsequent price performance of each operation.

Price changes after purchases and sales
Compare different holding periods
Inspect the underlying transactions and evidence

Explore Signals Pro

Illustrative example · simulated data, not results for this insider

Recent filings

Recent public filings linked to this insider party
Date	Issuer	Type	Gross reported value (EUR)	Open
6 Mar 2023	ABIVAX	InitialEffective	Buy €9,977,500.00 Buy/sale net: €9,977,500.00	Open

ABIVAX

6 Mar 2023

Buy

€9,977,500.00

Evidence

Supporting information

ABIVAX

InitialEffective

Buy/sale net: €9,977,500.00

Network and companies

1 distinct company in the disclosed relationships. Network coverage is a separate preview.

Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.

How to cite this record

OpenInsider. “SOFINNOVA PARTNERS SAS”. Record insider:fr:amf:RS00005948%7CLEGAL_ENTITY%7Csofinnova%20partners%20sas. https://openinsider.eu/en/insiders/insider%3Afr%3Aamf%3ARS00005948%257CLEGAL_ENTITY%257Csofinnova%2520partners%2520sas Regulatory source: AMF. The official publication remains authoritative.

Profiles and figures may change with new filings and corrections. Record the period and access date when reusing a figure; this link is not a historical snapshot.